A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Clinical trial NCT07003100 · RECRUITING

Trial details

NCT number: NCT07003100
Sponsor: City of Hope Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Recurrent Mycosis Fungoides Recurrent Sezary Syndrome Refractory Mycosis Fungoides Refractory Sezary Syndrome Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8

Start date: 2024-12-06
Primary completion: 2026-10-19
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.